OasisLMS

Release date: September 10, 2026

SCCM Product Code: WEBSEC26D

View the Society of Critical Care Medicine Privacy Statement 

SCCM copyrights the contents of all material available on this site unless otherwise indicated. You may not modify, reproduce or distribute the content on this site, the design or layout of the site, or the SCCM logo without written permission.

This site and/or course may contain active/live links, materials, or information provided by third parties. The active/live links, materials, or information are those of the respective third party and not of the Society or its affiliates. The Society makes no representation with respect to such third-party links, materials, or information, nor does the Society guarantee or endorse the quality, non-infringement, accuracy, completeness, timeliness, or reliability of such third-party links, materials, or information. Use of the links, materials, or information from said third party is voluntary, and your reliance on it should be undertaken only after an independent review of its accuracy, completeness, efficacy, and timeliness. 

Review the software/hardware and internet requirements here.

• Understand the rationale behind the FXI inhibitor category of anticoagulants and the pharmacology of drugs in this class
• Critically evaluate the primary literature exploring the efficacy and safety of FXI inhibitors
• Describe the management of patients taking FXI inhibitors who require urgent surgery or present with major bleeding

This activity is intended to meet the needs of all practitioners who care for critically ill patients. 

To provide due process in the evaluation and mediation of grievances concerning ACE activities, this Grievance Procedures Policy was developed. Grievances may concern, but are not limited to, the awarding of credit for individual participation and/or registration fees issues.

• A written complaint or grievance should be submitted to the Education Department.
• The Education Department will attempt to resolve the grievance of the complainant.
• If the initial response is unsatisfactory to the complainant, the matter will be referred to the Chief Executive Officer (CEO)/Executive Vice President (EVP) for action.
• If the response from the CEO/EVP is unsatisfactory to the complainant, the matter will be referred to the SCCM Executive Committee. The ruling of the Executive Committee will be final.